Rahul Kumar | Medicinal Chemistry | Best Researcher Award

Published on by Chemical Scientist

Best Researcher Award

Rahul Kumar
Vidya University
Rahul Kumar
Affiliation Vidya University
Country India
Scopus ID 59527213500
Documents 1
Citations 7
h-index 1
Subject Area Pharmaceutical Chemistry
Event International Chemical Scientist Awards
ORCID 0009-0001-0237-3201

The Best Researcher Award profile highlights the academic background, research activity, and scholarly contributions of Rahul Kumar in the field of Pharmaceutical Chemistry. The profile summarizes research achievements, publication records, citation performance, and suitability for recognition through the International Chemical Scientist Awards program.[1]

Abstract

Rahul Kumar is associated with research activities in Pharmaceutical Chemistry, contributing to scientific investigation and academic dissemination through peer-reviewed publication. His scholarly profile demonstrates participation in research addressing pharmaceutical and chemical sciences while maintaining measurable citation visibility within indexed academic databases.[1][2]

Keywords

Pharmaceutical Chemistry, Drug Research, Chemical Sciences, Scientific Publication, Citation Analysis, Academic Research, Research Excellence, Chemical Innovation, Scholarly Impact, Best Researcher Award.[1]

Introduction

Pharmaceutical Chemistry integrates chemical principles with biological and medical applications to support drug discovery and therapeutic development. Researchers in this field contribute to the understanding of molecular interactions, formulation strategies, and medicinal innovation. Rahul Kumar’s academic activities reflect engagement with these objectives through scholarly research and publication efforts.[1][2]

Research Profile

Rahul Kumar is affiliated with Vidya University and maintains a Scopus-indexed author profile documenting research output in Pharmaceutical Chemistry. Available bibliometric indicators include one indexed document, seven citations, and an h-index of one. These metrics provide an overview of scholarly engagement and research visibility within the scientific community.[1][3]

Research Contributions

The research contributions attributed to Rahul Kumar are associated with scientific inquiry in pharmaceutical and chemical sciences. His work contributes to the broader knowledge base supporting drug-related studies, analytical methodologies, and academic discussion. Such contributions assist in advancing evidence-based understanding within specialized areas of chemical and pharmaceutical research.[2][3]

Publications

Publication records serve as a primary indicator of scholarly communication and research dissemination. Rahul Kumar’s indexed publication activity demonstrates participation in peer-reviewed scientific literature. The documented research output contributes to citation accumulation and provides a foundation for evaluating academic productivity, research quality, and scientific engagement within Pharmaceutical Chemistry.[1][4]

Research Impact

Research impact may be evaluated through citations, scholarly visibility, and influence on subsequent investigations. With seven citations recorded within Scopus-linked metrics, Rahul Kumar’s research has received measurable recognition from the academic community. Citation-based indicators suggest that published findings have contributed to ongoing scientific discourse and reference activity.[1]

Award Suitability

The Best Researcher Award recognizes individuals demonstrating meaningful engagement in scientific research and academic dissemination. Rahul Kumar’s documented publication record, citation performance, institutional affiliation, and participation in Pharmaceutical Chemistry research align with common evaluation criteria considered in scholarly recognition programs and scientific award assessments.[3]

Conclusion

Rahul Kumar’s academic profile reflects participation in Pharmaceutical Chemistry research supported by indexed publication activity and measurable citation indicators. His scholarly contributions, institutional association, and engagement with scientific communication demonstrate characteristics commonly associated with developing research careers and academic recognition within specialized scientific disciplines.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Rahul Kumar, Author ID 59527213500. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=59527213500
  2. International Chemical Scientist Awards. (n.d.). Research excellence and scientific recognition guidelines.
    https://chemicalscientists.com
  3. Sah, A. K., Patel, S., Kumar, R., Mishra, P. S., Mishra, R., Umarovich, A. I., Elshaikh, R. H., Agarwal, S., Bhardwaj, A., Choudhary, R. K., & Alfeel, A. H. (2026). Therapeutic applications of natural products in biomedicine and pharmacotherapy. Life, 16(6), 873.

    https://doi.org/10.3390/life16060873

  4. Shukla, B., Kumar, R., Vasishtha, D., & Taghizadeh-Hesary, F. (2026). Current challenges in prostate cancer biosensing. In S. Srivastava, M. R. Babu, & S. Shekhar (Eds.), Biosensor Technologies for Prostate Cancer (pp. 297–325). Springer Nature Singapore.

    https://doi.org/10.1007/978-981-95-8644-8_11

Gunjan Jadon | Medicinal Chemistry | Women Researcher Award

Published on by Chemical Scientist

Dr. Gunjan Jadon | Medicinal Chemistry | Women Researcher Award

Professor | Pacific College of Pharmacy | India

Dr. Gunjan Jadon is an emerging researcher in pharmaceutical analysis and analytical chemistry, known for her contributions to quality-centered method development and scientific rigor. With a growing academic profile reflected through 3 peer-reviewed publications, 54 citations, and an h-index of 2, she has steadily established her presence within the analytical science community. Her research focuses on chromatographic method development, impurity assessment, pharmaceutical quality control, and the systematic application of Analytical Quality by Design (QbD) principles. One of her notable works includes the development and validation of a QbD-based RP-HPLC method for the quantification of dobutamine, demonstrating her expertise in experimental optimization, response-surface modeling, and regulatory aligned method validation. Dr. Jadon’s broader research interests integrate risk assessment, analytical robustness studies, and the enhancement of method precision and reproducibility to support high-quality pharmaceutical evaluation. She actively collaborates with multidisciplinary teams of pharmaceutical scientists and analytical chemists, strengthening the practical and translational impact of her findings. Her work contributes to improving drug-evaluation workflows, ensuring analytical reliability, and promoting safer therapeutic outcomes across the pharmaceutical sector. Beyond her research outputs, she remains engaged in scientific dialogue through collaborative networks, co-authored studies, and participation in academic platforms aimed at advancing analytical science. Her contributions hold societal relevance by supporting the development of robust analytical frameworks that enhance the quality, safety, and consistency of pharmaceutical products. Driven by a commitment to scientific integrity and continuous innovation, Dr. Jadon continues to explore emerging analytical challenges while expanding the methodological landscape of pharmaceutical research, demonstrating promise as a dedicated and impactful early-career scientist.

Profiles : Google Scholar | Scopus | ResearchGate

Featured Publications

1. Dahiya, R., Dahiya, S., Fuloria, N. K., Kumar, S., Mourya, R., Chennupati, S. V., et al. (2020). Natural bioactive thiazole-based peptides from marine resources: Structural and pharmacological aspects. Marine Drugs, 18(6), 329.

2. Joshi, S. K., Bhadauria, R. S., & Diwaker, A. K. (2012). Introduction to neoplasm: Tumor classification – A review article. International Journal of Advanced Research in Pharmaceutical & Bio Sciences, 22.

3. Jadon, G., & Kumawat, L. (2011). Synthesis, spectral and biological evaluation of some phenyl acetic acid hydrazone derivatives. International Journal of Pharmaceutical Sciences and Research, 2(10), 2572.

4. Gunjan, J., & Kumawat, L. (2011). Synthesis, spectral and biological evaluation of some hydrazone derivatives. International Journal of Pharmaceutical Sciences and Research, 2(9), 2408–2412.

5. Gunjan, J., Rahul, N., Divya, S., Praveen, K. S., & Diwaker, K. A. (2012). Antioxidant activity of various parts of Punica granatum: A review. Journal of Drug Delivery & Therapeutics, 2, 138–141.

Gunjan Jadon’s work advances analytical chemistry and pharmaceutical quality assurance by developing robust, regulatory-aligned methods that improve drug safety and evaluation. Her research contributes to more reliable therapeutic quality control, supporting innovation, precision, and societal well-being across the pharmaceutical sector.

Vidyasrilekha Sanapalli | Medicinal Chemistry | Excellence in Innovation Award

Published on by Chemical Scientist

Dr. Vidyasrilekha Sanapalli | Medicinal Chemistry | Excellence in Innovation Award

Assistant Professor| SVKM’S NMIMS University| India

Dr. Vidyasrilekha Sanapalli is a medicinal and process chemist whose expertise bridges synthetic organic chemistry, computational chemistry, and pharmaceutical sciences, with a research focus on antibacterial agents, anticancer compounds, and diabetic wound therapeutics. She earned her Ph.D. in Pharmaceutical Chemistry as an AICTE National Doctoral Fellow from JSS Academy of Higher Education and Research, Mysuru (JSS College of Pharmacy, Ooty) in 2021, where her work combined synthesis, structure–activity relationship (SAR) studies, and advanced computational approaches such as molecular docking, molecular dynamics, and 3D-QSAR modeling. Prior to this, she obtained her M.Tech (Pharma) in Process Chemistry from NIPER Hyderabad (2016–2018) with a perfect CGPA of 10/10, securing the gold medal for academic excellence, and completed her B. Pharm from Osmania University in 2016, also as a gold medalist. Dr. Sanapalli’s career reflects a strong integration of academic excellence, innovative research, and impactful teaching. She has served as an Assistant Professor at Marwadi University, NIMS University, and currently at NMIMS University, where she teaches medicinal chemistry, pharmaceutical analysis, and related courses while mentoring students in cutting-edge research. Her research portfolio is extensive, with contributions in the design, synthesis, and computational evaluation of novel antibacterial scaffolds, the development of repurposed immune-stimulating and antidiabetic wound-healing agents, and the investigation of heterocyclic derivatives for therapeutic applications. She has published over 28 research papers in high-impact SCI-indexed journals, filed three Indian patents (two granted), and secured competitive fellowships and grants, including the prestigious AICTE National Doctoral Fellowship, NIPER Fellowship, and a Marwadi University Seed Grant. Dr. Sanapalli has also delivered invited lectures, such as her talk on structure-based drug design at RBVRR Women’s College of Pharmacy, Hyderabad, highlighting her contributions to knowledge dissemination. Her outstanding research achievements have been recognized through numerous awards, including the Best Women Researcher Award (2021), Young Researcher Award (2020), and multiple gold medals for academic excellence during her M.Tech and B. Pharm studies.With strong expertise in organic synthesis, process optimization, green chemistry, purification techniques, and structural elucidation, coupled with advanced skills in computational drug design using Schrödinger, Maestro, and molecular modeling tools, Dr. Sanapalli brings a rare multidisciplinary perspective to pharmaceutical research. Her scientific vision is centered on developing novel chemical entities and innovative therapeutic strategies to tackle multidrug resistance, cancer, and chronic conditions such as diabetic wounds. As a life member of InSc and APTI and a registered pharmacist under the Telangana Pharmacy Council, she remains deeply engaged with both the scientific community and professional practice. Through her diverse body of work, Dr. Vidyasrilekha Sanapalli exemplifies the synergy of academic brilliance, research innovation, and translational impact in medicinal chemistry.

Profile: Google Scholar | ORCID 

Featured Publications

  1. Sanapalli BKR, Yele V, Singh MK, Krishnamurthy PT, Karri VVSR. Preclinical models of diabetic wound healing: A critical review. Biomed Pharmacother. 2021;142:111946. Cited by 55

  2. Sanapalli BKR, Ashames A, Sigalapalli DK, Shaik AB, Bhandare RR, et al. Synthetic imidazopyridine-based derivatives as potential inhibitors against multi-drug resistant bacterial infections: A review. Antibiotics. 2022;11(12):1680. Cited by 31

  3. Yele V, Azam MA, Wadhwani AD. Synthesis, molecular docking and biological evaluation of 2‐Aryloxy‐N‐Phenylacetamide and N′‐(2‐Aryloxyoxyacetyl) benzohydrazide derivatives as potential … Chem Biodivers. 2021;18(4):e2000907. Cited by 29

  4. Singh MK, Pindiprolu SKSS, Sanapalli BKR, Yele V, Ganesh GNK. HER2 targeted biological macromolecule modified liposomes for improved efficacy of capecitabine in breast cancer. Int J Biol Macromol. 2020;150:631-636. Cited by 25

  5. Sanapalli BKR, Yele V, Singh MK, Thumbooru SN, Parvathaneni M, et al. Human beta defensin-2 loaded PLGA nanoparticles impregnated in collagen-chitosan composite scaffold for the management of diabetic wounds. Biomed Pharmacother. 2023;161:114540. Cited by 22

  6. Sanapalli BKR, Yele V, Jupudi S, Karri VVSR. Ligand-based pharmacophore modeling and molecular dynamic simulation approaches to identify putative MMP-9 inhibitors. RSC Adv. 2021;11(43):26820-26831. Cited by 22

  7. Singh MK, Pindiprolu SKSS, Sanapalli BKR, Yele V, Ganesh GNK. Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer: In vitro studies. RSC Adv. 2019;9(43):24987-24994. Cited by 21

  8. Yele V, Sigalapalli DK, Jupudi S, Mohammed AA. DFT calculation, molecular docking, and molecular dynamics simulation study on substituted phenylacetamide and benzohydrazide derivatives. J Mol Model. 2021;27(12):359. Cited by 18

  9. Yele V, Pindiprolu SKSS, Sana S, Ramamurty D, Madasi JRK, et al. Synthesis and preclinical evaluation of indole triazole conjugates as microtubule targeting agents that are effective against MCF-7 breast cancer cell lines. Anti-Cancer Agents Med Chem. 2021;18: [page numbers not provided]. Cited by 18

  10. Sanapalli BKR, Yele V, Kalidhindi RSR, Singh SK, Gulati M, Karri VVSR. Human beta defensins may be a multifactorial modulator in the management of diabetic wound. Wound Repair Regen. 2020;28(3):416-421. Cited by 16

  11. Yele V, Sanapalli BKR, Mohammed AA. Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach. Chem Pap. 2022;76(2):1107-1117. Cited by 12

  12. Yele V, Mohammed AA, Wadhwani AD. Synthesis and evaluation of aryl/heteroaryl benzohydrazide and phenylacetamide derivatives as broad‐spectrum antibacterial agents. ChemSelect. 2020;5(34):10581-10587. Cited by 10